Burden of cardiovascular diseases attributable to risk factors in brazil: data from the global burden of disease 2019 study

• Autor(a) principal: Luisa Campos Caldeira Brant
• Data de Publicação: 2021
• Outros Autores: Deborah Carvalho Malta, Bruno Ramos Nascimento, Guilherme Augusto Veloso, Crizian Saar Gomes, Carisi Polanczyk, Gláucia Maria Moraes de Oliveira, Luisa Flor, Emmanuela Gakidou, Antonio Luiz Pinho Ribeiro
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFMG
• Texto Completo: https://doi.org/10.1590/0037-8682-0263-2021; http://hdl.handle.net/1843/62520
• topic: Cardiovascular Diseases; Risk factors; Population attributable risk; Cardiovascular Diseases; Risk factors.; Global Burden of Disease

To better understand trends in the main cause of death in Brazil, we sought to analyze the burden of cardiovascular risk factors (RF) and cardiovascular diseases (CVD) attributable to specifi c RFs in Brazil from 1990 to 2019, using the estimates from the GBD 2019 study. Methods: To estimate RF exposure, the Summary Exposure Value (SEV) was used, whereas for disease burden attributed to RF, mortality and disability-adjusted life-years (DALY) due to CVD were used. For comparisons over time and between states, we compared age-standardized rates. The sociodemographic index (SDI) was used as a marker of socioeconomic conditions. Results: In 2019, 83% of CVD mortality in Brazil was attributable to RF. For SEV, there was a reduction in smoking and environmental RF, but an increase in metabolic RF. High systolic blood pressure and dietary risks continue to be the main RF for CVD mortality and DALY. While there was a decline in age-standardized mortality rates attributable to the evaluated RF, there was also a stability or increase in crude mortality rates, with the exception of smoking. It is important to highlight the increase in the risk of death attributable to a high body mass index. Regarding the analysis per state, SEVs and mortality attributable to RF were higher in those states with lower SDIs. Conclusions: Despite the reduction in CVD mortality and DALY rates attributable to RF, the stability or increase in crude rates attributable to metabolic RFs is worrisome, requiring investments and a renewal of health policies